BI 847325

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 847325, covering 2018-12-21 to 2018-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Monotherapy Dose Finding With BI 847325 in Solid Tumours [Phase 1]